HB 1724
House sustained Governor's veto
Prescription Drug Affordability Board; established, drug cost affordability review, report.
- Virginia
- House / Assembly
- Introduced Jan 4, 2025
- Session 2025
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Virginia’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
35 actions-
House sustained Governor's veto
-
Vetoed by Governor
-
Governor's Action Deadline 11:59 p.m., March 24, 2025
-
Enrolled Bill communicated to Governor on March 11, 2024
-
Signed by President
-
Signed by Speaker
-
Fiscal Impact Statement from Department of Planning and Budget (HB1724)
-
Enrolled
-
Fiscal Impact Statement from Department of Planning and Budget (HB1724)
-
Senate substitute agreed to by House (52-Y 45-N)
-
Passed Senate with substitute (26-Y 14-N)
-
Reconsideration of Senate passage agreed to by Senate
-
Passed Senate with substitute (24-Y 16-N)
-
Engrossed by Senate - committee substitute
-
Finance and Appropriations Substitute agreed to
-
Reading of substitute waived
-
Read third time
-
Passed by for the day
-
Constitutional reading dispensed (on 2nd reading) (39-Y 0-N)
-
Rules suspended
-
Committee substitute printed 25107574D-S1
-
Reported from Finance and Appropriations with substitute (10-Y 4-N)
-
Reported from Commerce and Labor and rereferred to Finance and Appropriations (10-Y 5-N)
-
Referred to Committee on Commerce and Labor
-
Constitutional reading dispensed (on 1st reading)
-
Read third time and passed House (52-Y 44-N)
-
Read second time and engrossed
-
Read first time
-
Reported from Appropriations (14-Y 8-N)
-
Subcommittee recommends reporting (5-Y 2-N)
-
Fiscal Impact Statement from Department of Planning and Budget (HB1724)
-
Assigned Approps sub: Health & Human Resources
-
Reported from Labor and Commerce and referred to Appropriations (12-Y 10-N)
-
Referred to Committee on Labor and Commerce
-
Prefiled and ordered printed; Offered 01-08-2025 25100998D